Cases & Deals

Athyrium Capital Management refinances Biom'Up's existing debt, finances production and marketing of HEMOBLAST™ Bellows, and completes bond financing

Clients Athyrium Capital Management, LP

Jones Day represented Athyrium Capital Management in connection with the refinancing of Biom'Up's existing debt, financing of the production and marketing of its flagship product HEMOBLAST™ Bellows in the United States and the European Union, and the financing of its external growth. Athyrium Capital acted as sole lender through the issuance of bonds subscribed by its fund Athyrium Opportunities III Acquisition LP.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.